We report the occurrence of renal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous recombinant tissue-type plasminogen activator (t-PA).
cholesterol crystal embolization
t-PA
cholesterol crystal embolization
recombinant tissue-type plasminogen activator
renal failure
recombinant tissue-type plasminogen activator
renal failure
t-PA